Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Intraperitoneal and Appendiceal Malignancies, and Uterine Myomas and Treatments.
Endometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis
Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer
Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention
Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer
A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies
Can you ask? We just did! Assessing sexual function and concerns in patients presenting for initial gynecologic oncology consultation
Patterns and utility of routine surveillance in high grade endometrial cancer
Nanomedicine for Combination Therapy of Cancer
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
Pathologic Findings at Risk-Reducing Salpingo-Oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199
Statin Therapy Is Associated with Improved Survival in Patients with Non-Serous-Papillary Epithelial Ovarian Cancer: A Retrospective Cohort Analysis
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study